The recent instability in global distribution have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to significant vulnerabilities, including shipping delays, price fluctuations, and even geopolitical concerns. Shifting towards domestic production of Ivermectin offers a